Equity in Access Research Grants support researchers studying insurance-related barriers to blood cancer care and actionable solutions to improve equitable access for patients and survivors.
Specialized Center of Research Program (SCOR) supports interdisciplinary investigator teams pursuing integrated blood cancer research to move laboratory discoveries toward clinical use.
Academic Clinical Trials Program (ACT) supports academic investigators conducting blood cancer trials to test new treatments, expand existing therapy uses, and improve care for unmet medical needs.
Gilead Sciences funds research and programs addressing social and economic barriers to health equity in cancer care for underserved communities in several countries.
ACCESS Award supports clinical research teams testing low-cost, scalable cancer interventions to improve treatment and expand equitable access worldwide, particularly in low- and middle-income countries.
Research Grant Program - Children's Leukemia Research Association supports doctors studying leukemia and blood cancers to identify causes, improve treatments, and advance toward a cure.